NEUE IMMUNOGENISCHE PEPTIDE

European patent · EP3207053 · In force

Register entry

Publication number
EP3207053
Application number
EP15787917
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 16, 2015
Published
Aug 23, 2017
Granted
Aug 21, 2019
Protection ends at the latest
Oct 15, 2035
Next annual fee due
Oct 31, 2026
IPC classes
C07K 14/74 (2006.01)
A61K 47/50 (2017.01)
C07K 14/47 (2006.01)
Priority
GB 201418433 17.10.2014
PCT application
PCT/EP2015/074063 16.10.2015
PCT publication
WO2016/059236 21.04.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Apr 23, 2025

    Change

    Published in Swissreg on 23.04.2025

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Sep 14, 2019

    Agent entered

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in Swissreg on 14.09.2019

  6. Aug 21, 2019

    Granted

    Published in Swissreg on 21.08.2019

Parties

Holder

Imcyse SA

ImCyse SA

GIGA B34 Avenue de l'Hôpital 1, 4000 Liège, BE

Agent

Ing. Marco Zardi c/o M. ZARDI & Co. S.A.

via Pioda 6, 6900 Lugano

Inventor

BURKHART, David

Missoula, MT59803, US

SAINT-REMY, Jean-Marie

B-1390 Grez-Doiceau, BE

VANDER ELST, Luc

B-6230 Obaix, BE

CARLIER, Vincent

B-1350 Enines, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.